Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-11-15FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approves Westminster Pharmaceuticals' supplemental application for risperidone (generic), updating its approved status under an ANDA.
-
FDA approval · 2011-11-10FDA Approved: RISPERIDONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic risperidone product from Aurobindo Pharma Limited.
-
FDA approval · 2011-11-09FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for SEROQUEL (quetiapine) from H2-Pharma, LLC.
-
FDA approval · 2011-11-09FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA has approved a supplemental application for SEROQUEL XR (quetiapine) by AstraZeneca Pharmaceuticals LP. The approval pertains to mod…
-
FDA approval · 2011-11-08FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application to approve a generic risperidone product from Amneal Pharmaceuticals LLC under ANDA 091384.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-11-04FDA Approved: RISPERIDONE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved Jubilant Cadista's generic risperidone under an Original Application (ANDA 090839).
-
FDA approval · 2011-10-25FDA Approved: OLANZAPINE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved the Original Application for olanzapine from Torrent Pharmaceuticals Limited, marking the introduction of a generic olanzapine …
-
FDA approval · 2011-10-24FDA Approved: OLANZAPINE — Original Application (Sandoz Inc)
FDA approved the Original Application for olanzapine from Sandoz Inc., making a generic olanzapine available (ANDA 201588).
-
FDA approval · 2011-10-24FDA Approved: OLANZAPINE — Original Application (Dr. Reddy's Laboratories Ltd.)
FDA approved an original generic application for olanzapine from Dr. Reddy's Laboratories Ltd.
-
FDA approval · 2011-10-24FDA Approved: OLANZAPINE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original ANDA for generic olanzapine (olanzapine tablets). The product is indicated for schizophrenia and bipola…
-
FDA approval · 2011-10-24FDA Approved: OLANZAPINE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's original application for a generic olanzapine product (ANDA076534), enabling market entry of…
-
FDA approval · 2011-10-19FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA approval · 2011-09-27FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for haloperidol decanoate from Hikma Pharmaceuticals USA Inc., updating the approved generic long-ac…
-
FDA approval · 2011-09-27FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for haloperidol decanoate from Fresenius Kabi USA, LLC. This action relates to continued approval of…
-
FDA approval · 2011-09-27FDA Approved: RISPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for risperidone, granting approval of a generic risperidone product. This is …
-
FDA approval · 2011-09-26FDA Approved: LOXAPINE — Original Application (Lannett Company, Inc.)
The FDA approved the original application for LOXAPINE from Lannett Company, Inc., providing a generic loxapine product. Loxapine is an anti…
-
FDA approval · 2011-09-24FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved Janssen's supplemental application for Risperdal M-TAB (risperidone), adding the M-TAB dosage form to the approved product.…
-
FDA approval · 2011-09-24FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, signaling an approved update to the…
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC. This action represents a regul…
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC (ANDA 084115).
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2011-09-07FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
The FDA approved a supplemental application for Fanapt (iloperidone) from Vanda Pharmaceuticals Inc.
-
FDA approval · 2011-09-02FDA Approved: HALOPERIDOL — Original Application (Sagent Pharmaceuticals)
FDA approved HALOPERIDOL lactate injectable as an Original Application by Sagent Pharmaceuticals. This adds a generic HALOPERIDOL lactate pr…
-
FDA approval · 2011-08-26FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Risperidone by Torrent Pharmaceuticals Limited, indicating approval of a generic version of the …